Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Genetic Technologies.
RELATED STOCKHEAD STORIES
News
Top 10 at 10: A rogue move by ex PM Scott Morrison could be repealed, and these stocks will benefit
News
Top 10 at 10: Which ASX silver explorer just surged +100pc at the open?
News
LAST ORDERS: Come and warm yourself by the crackling dumpster fire of another Wednesday
News
ASX Quarterlies: Junior techs and biotechs still thriving despite difficult conditions
Health & Biotech
Check Up: Only two healthcare IPOs from 2021 are gaining ground, could the rest be buying opportunities?
Health & Biotech
ASX Health Stocks: New dawn for Alzheimer’s after Biogen’s landmark results; Cogstate soars by proxy
Health & Biotech
ASX Health Stocks: Ansell commits to net zero by 2040, but says Scope 3 needs more work
Health & Biotech
ASX Health Stocks: Another Aussie biotech gets attention in the US with a pending patent
News
Top 10 at 10: Which ASX stocks are doing the heavy lifting today?
News
Closing Bell: Australia lifts small cap rate by 2%
Health & Biotech
ASX Health Stocks: US patent another Prescient win for booming Aussie biotechs
Health & Biotech
ASX Health Stocks: Proteomics proves it can manufacture at scale, GTG sees pathway to the US
Health & Biotech
ASX Health Stocks: GTG set to jump into online after buying ecommerce outfit AffinityDNA
Health & Biotech
ASX Health Stocks: Genetic Tech is now lab certified and begins rollout of its geneType Multi-Test
News
Top 10 at 10: These ASX stocks are today’s biggest movers
News
Closing Bell: ASX dips, while a battery metals IPO rips higher on debut
News